See All AI raises $33M to advance its AI platform that generates 3D surgical images from 2D fluoroscopic X-rays, potentially reducing reliance on pre-op CT and MRI scans.
Key Details
- 1See All AI secured $33 million in funding for its imaging AI platform.
- 2The system converts 2D C-arm fluoroscopic X-rays into 'navigable' 3D volumes.
- 3Aims to reduce the need for pre-operative CT and MRI imaging.
- 4Platform is designed to support minimally invasive surgery workflows.
- 5Technology is not yet FDA-cleared or available clinically; U.S. approval sought this year.
- 6Cadaver studies show capability for high-resolution, cross-plane, 1 mm 3D slices.
Why It Matters
If successful, this technology could streamline surgical planning and reduce costs, radiation, and time in the operating room. It highlights growing industry investment and innovation aimed at augmenting or replacing traditional radiology workflows in perioperative imaging.
Source
Radiology Business
Related News
•AuntMinnie
GPT-4o AI Matches Radiologists in Follow-Up Imaging Recommendations
GPT-4o matched the performance of experienced radiologists and surpassed residents in recommending follow-up imaging from routine radiology reports.
•Cardiovascular Business
AI Leverages Head CTs for Automated Heart Risk Assessments
AI models can turn routine head CT scans into automated cardiovascular risk assessments, expanding the utility of radiology studies.
•Radiology Business
MRI AI for Parkinsonian Syndrome Gains FDA De Novo Clearance
Neuropacs Corp.'s MRI AI software earns FDA De Novo classification to assist in Parkinsonian syndrome diagnosis.